This opportunity is no longer accepting applications.
grant PAR-21-330

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

This grant opportunity invites applications for research on cancer causes and early detection biomarkers using the biorepository resources from the PLCO Screening Trial. The biorepository provides quality blood samples collected before diagnosis and buccal cells, along with associated data like demographics, lifestyle, and clinical information. The research should focus on cancer risk analysis…

This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Ca…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: September 8, 2021
Application Window Closes: October 11, 2024
Open for Submission: September 8, 2021
Submission Deadline: October 11, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.